Found 9 results
Author Keyword Title [ Type(Desc)] Year
Filters: Author is van Breemen, Richard B and First Letter Of Keyword is S  [Clear All Filters]
Journal Article
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
van Breemen RB, Simchuk D.  2023.  Antiviral activities of hemp cannabinoids.. Clin Sci (Lond). 137(8):633-643.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Fang J-B, Nikolic D, Lankin DC, Simmler C, Chen S-N, Alvarenga RFRamos, Liu Y, Pauli GF, van Breemen RB.  2019.  Formation of (2)- and (2)-8-Prenylnaringenin Glucuronides by Human UDP-Glucuronosyltransferases.. J Agric Food Chem. 67(42):11650-11656.
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Rush MD, Rue EA, Wong A, Kowalski P, Glinski JA, van Breemen RB.  2018.  Rapid Determination of Procyanidins Using MALDI-ToF/ToF Mass Spectrometry.. J Agric Food Chem. 66(43):11355-11361.